20 studies found for:    Open Studies | "Tinea"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
Conditions: Fungal Infections;   Tinea Pedis;   Tinea Cruris;   Tinea Corporis
Intervention: Drug: Clotrimazole
2 Unknown  Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females
Conditions: Tinea Pedis;   Athlete's Foot;   Foot Fungus;   Ringworm
Intervention: Drug: Sertaconazole nitrate cream 2%
3 Unknown  Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)
Condition: Tinea Pedis
Intervention: Drug: Topical therapy
4 Unknown  Spread of Dermatophytes Among Families
Conditions: Onychomycosis;   Tinea Pedis
Intervention:
5 Recruiting Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
Condition: Onychomycosis
Intervention: Device: Laser Treatment (Pulsed Nd:YAG 1064 nm Laser)
6 Recruiting Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis
Condition: Onychomycosis
Interventions: Device: Er:YAG laser + amorolfine lacquer;   Drug: Amorolfine lacquer
7 Unknown  Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole
Condition: Onychomycosis
Interventions: Drug: 3 mg terbinafine and 2 mg ketoconazole containing patch;   Drug: 6 mg terbinafine and 2 mg ketoconazole containing patch;   Drug: 8 mg terbinafine and 2 mg ketoconazole containing patch
8 Recruiting Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
Condition: Onychomycosis
Interventions: Drug: ME1111 Solution, Low strength;   Drug: ME1111 Solution, High strength;   Drug: Matching Vehicle Solution
9 Unknown  Using Light Therapy to Treat Toe Nail Fungus
Condition: Onychomycosis
Intervention: Device: light therapy
10 Unknown  Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis
Condition: Onychomycosis
Interventions: Drug: Amorolfine (Antifungal);   Drug: RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
11 Not yet recruiting Laser Treatment for Onychomycosis in Diabetes
Conditions: Diabetes Mellitus, Type 2;   Onychomycosis
Interventions: Device: Laser Treatment YAG laser;   Drug: Standard Treatment (control group) terbinafine HCl
12 Recruiting Pilot Study to Evaluate Plasma Treatment of Onychomycosis
Condition: Onychomycosis
Intervention: Device: MOE Antimicrobial Plasma Treatment System
13 Recruiting Pulsed Dye Laser Treatment of Onychomycosis
Condition: Onychomycosis
Intervention: Device: Pulsed Dye Laser for the treatment of nail fungus
14 Not yet recruiting A Clinical Investigation to Evaluate the Safety and Performance of a Treatment Kit for Ingrowing Toenail
Condition: Onychomycosis of Toenails
Intervention: Device: Ingrowing Toenail Treatment Kit
15 Unknown  Treating Onychomychosis
Condition: Onychomycosis
Intervention: Device: Noveon laser
16 Unknown  Efficacy and Safety of RV4104A Ointment in Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Keratolytic/Antifungal
17 Recruiting Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis
Condition: Onychomycosis of Toenails
Intervention: Device: PinPointe Foot Laser
18 Recruiting A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis
Condition: Onycomycosis
Interventions: Drug: Phytonail;   Drug: Loceryl
19 Not yet recruiting Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications
Condition: Onychomycosis
Interventions: Device: Nd:YAG laser pulse therapy;   Device: Sham procedure
20 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure)
Intervention: Drug: Ampicillin

Indicates status has not been verified in more than two years